361 related articles for article (PubMed ID: 35414485)
41. How COVID-19 has impacted the role of pharmacists around the world.
Jordan D; Guiu-Segura JM; Sousa-Pinto G; Wang LN
Farm Hosp; 2021 Feb; 45(2):89-95. PubMed ID: 33709893
[TBL] [Abstract][Full Text] [Related]
42. Maximizing pharmacists' scope of practice.
Clark JS; Knoer SJ; Waier KA; Montgomery DR; Cesarz J; Chapman NRM; Kotis D
Am J Health Syst Pharm; 2022 Aug; 79(16):1397-1401. PubMed ID: 35219279
[No Abstract] [Full Text] [Related]
43. Community pharmacist perceptions of increased technician responsibility.
Sparkmon W; Barnard M; Rosenthal M; Desselle S; Holmes E
J Am Pharm Assoc (2003); 2021; 61(4):382-389.e4. PubMed ID: 33853751
[TBL] [Abstract][Full Text] [Related]
44. Cross-sectional questionnaire study of the experiences of community pharmacists in Northern Ireland during the early phases of the COVID-19 pandemic: preparation, experience and response.
Patterson SM; Cadogan C; Barry HE; Bennett KE; Hughes C
BMJ Open; 2022 Sep; 12(9):e064545. PubMed ID: 36137621
[TBL] [Abstract][Full Text] [Related]
45. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
Xi X; Huang Y; Lu Q; Ung COL; Hu H
Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
[TBL] [Abstract][Full Text] [Related]
46. The introduction of the national e-health record into Australian community pharmacy practice: pharmacists' perceptions.
Mooranian A; Emmerton L; Hattingh L
Int J Pharm Pract; 2013 Dec; 21(6):405-12. PubMed ID: 23560554
[TBL] [Abstract][Full Text] [Related]
47. Critical care tele-pharmacy services during COVID-19 pandemic: A qualitative exploration of healthcare practitioners' perceptions.
Isleem N; Shoshaa S; AbuGhalyoun A; Khatib M; Naseralallah LM; Ibn-Mas'ud Danjuma M; Saad M
J Clin Pharm Ther; 2022 Oct; 47(10):1591-1599. PubMed ID: 35699243
[TBL] [Abstract][Full Text] [Related]
48. Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes.
Kibicho J; Pinkerton SD; Owczarzak J; Mkandawire-Valhmu L; Kako PM
J Am Pharm Assoc (2003); 2015; 55(1):19-30. PubMed ID: 25575148
[TBL] [Abstract][Full Text] [Related]
49. Changing status in health care: community and hospital pharmacists' perceptions of pharmacy practice.
Altman IL; Mandy PJ; Gard PR
Int J Pharm Pract; 2019 Jun; 27(3):249-255. PubMed ID: 30592351
[TBL] [Abstract][Full Text] [Related]
50. [Cooperation according to French Law "hospital, patients, health and territories": Pharmacists' involvement in Aquitaine region].
d'Elbée M; Baumevieille M; Dumartin C
Rev Epidemiol Sante Publique; 2017 Jun; 65(3):231-239. PubMed ID: 28262371
[TBL] [Abstract][Full Text] [Related]
51. Pharmacists' Perceptions, Barriers, and Potential Solutions to Implementing a Direct Pharmacy Access Policy in Indiana.
Newlon JL; Ades R; Vernon V; Wilkinson TA; Meredith AH
Med Care Res Rev; 2021 Dec; 78(6):789-797. PubMed ID: 33016218
[TBL] [Abstract][Full Text] [Related]
52. Impact of the COVID-19 Pandemic on the Community Pharmacy Workforce.
Bacci JL; Pollack SW; Skillman SM; Odegard PS; Danielson JH; Frogner BK
Med Care Res Rev; 2024 Feb; 81(1):39-48. PubMed ID: 37830446
[TBL] [Abstract][Full Text] [Related]
53. Pharmacists' role, work practices, and safety measures against COVID-19: A comparative study.
Novak H; Tadić I; Falamić S; Ortner Hadžiabdić M
J Am Pharm Assoc (2003); 2021; 61(4):398-407. PubMed ID: 33820717
[TBL] [Abstract][Full Text] [Related]
54. Pharmacists' use of guidelines for the supply of non-prescription medicines: a cross-sectional survey.
Mill D; Johnson JL; Percival M; Lee K; Salter SM; D'Lima D; Seubert L; Clifford R; Page AT
Int J Pharm Pract; 2023 Sep; 31(5):478-488. PubMed ID: 37440321
[TBL] [Abstract][Full Text] [Related]
55. Emerging Developments in Pharmacists' Scope of Practice to Address Unmet Health Care Needs.
Burns AL
Ann Pharmacother; 2016 Sep; 50(9):785-7. PubMed ID: 27340143
[TBL] [Abstract][Full Text] [Related]
56. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
Gordon C; Unni E; Montuoro J; Ogborn DB
Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
[TBL] [Abstract][Full Text] [Related]
57. Community pharmacists' perceptions, attitudes and barriers towards pharmacist-led minor ailment services in Malaysia.
Selvaraj A; Redzuan AM; Hatah E
Int J Clin Pharm; 2020 Apr; 42(2):777-785. PubMed ID: 32006142
[TBL] [Abstract][Full Text] [Related]
58. Community Pharmacists Roles During the COVID-19 Pandemic.
Hess K; Bach A; Won K; Seed SM
J Pharm Pract; 2022 Jun; 35(3):469-476. PubMed ID: 33317371
[TBL] [Abstract][Full Text] [Related]
59. Perspectives of pharmacists about collaborative asthma care model in primary care.
Qazi A; Saba M; Armour C; Saini B
Res Social Adm Pharm; 2021 Feb; 17(2):388-397. PubMed ID: 32284301
[TBL] [Abstract][Full Text] [Related]
60. Rapid realist review of the role of community pharmacy in the public health response to COVID-19.
Maidment I; Young E; MacPhee M; Booth A; Zaman H; Breen J; Hilton A; Kelly T; Wong G
BMJ Open; 2021 Jun; 11(6):e050043. PubMed ID: 34135054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
